24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Direct Offering
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
06:30
IAI nears $900 million India deal for six aerial refueling aircraft
21:53
Google, Amazon and Intel stumble as investors begin to question the price of the AI boom
12:53
Every student deserves a personal tutor, inside the classroom, too.
09:51
AI companies say their models are the best. Here's how to tell if that's true
More stories
Buzz
Most popular
Daily
Weekly
1
"A gorgeous situation": ServiceNow's CEO celebrates a shrinking workforce
2
Cyber startup Cyera eyes $20 billion valuation in new funding talks
3
Stealth Israeli cyber startup valued at over $1.5 billion recruits former 8200 chief
4
Intel’s $600 million question: How the Kiryat Gat explosion hit its forecast
5
BrainPOP's mind-blowing deal: Israeli founder nets $875 million from deal with Lego
More news
Direct Offering
4 stories about Direct Offering
Oral Insulin Capsule Developer Oramed Raises $18 Million in Direct Offering
10.07.18
|
CTech
Jerusalem-headquartered Oramed intends to use the recent proceeds for research and development and for clinical trials
Biotech Company Compugen Down on Nasdaq Following $21 Million Direct Offering
17.06.18
|
Dror Reich
The Israel-based cancer immunotherapy company intends to use the proceedings for product development
OrbiMed Invests $16 Million in Derma Company Foamix
17.04.18
|
Lilach Baumer
Foamix is a clinical-stage company developing specialty foam-based treatments for skin conditions such as acne
Liver Treatment Company Galmed is Raising $6 Million in Direct Offering
04.04.18
|
Lilach Baumer
The company’s stock fell by 37% on Nasdaq since the beginning of the year, and by 66% since its Nasdaq listing in 2014